Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.07 and traded as low as C$0.07. Resverlogix shares last traded at C$0.07, with a volume of 1,000 shares changing hands.
Resverlogix Stock Performance
The business has a fifty day moving average of C$0.07 and a 200-day moving average of C$0.06. The firm has a market capitalization of C$19.39 million, a P/E ratio of -1.40 and a beta of 0.71.
Resverlogix (TSE:RVX – Get Free Report) last announced its earnings results on Wednesday, August 14th. The biotechnology company reported C($0.02) earnings per share (EPS) for the quarter. On average, equities research analysts forecast that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.
Resverlogix Company Profile
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Trading Stocks: RSI and Why it’s Useful
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Best Aerospace Stocks Investing
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
